NP-C

OneOncology and Practice Partners to Present 11 Abstracts at ASCO Quality Care Symposium

Retrieved on: 
Tuesday, October 17, 2023

NASHVILLE, Tenn., Oct. 17, 2023 /PRNewswire/ -- OneOncology, the national platform for independent oncology practices, announced today that researchers at OneOncology and its partner practices will present 11 abstracts at the upcoming ASCO Quality Care Symposium October 27-28.

Key Points: 
  • Researchers to Present on Genetic Testing, Precision Medicine, Care Delivery & Physician Workforce Research
    NASHVILLE, Tenn., Oct. 17, 2023 /PRNewswire/ -- OneOncology, the national platform for independent oncology practices, announced today that researchers at OneOncology and its partner practices will present 11 abstracts at the upcoming ASCO Quality Care Symposium October 27-28.
  • Neha Jain, Ph.D., OneOncology's Senior Director of Precision Medicine, will present "Provider Messaging for Precision Treatment (ProMPT): A Notification Pilot to Inform Actionable Genomic Findings."
  • The next iteration of ProMPT will use OneOncology's proprietary analytics platform to incorporate genomic information into our physicians' workstream.
  • Tennessee Oncology researchers will present six abstracts addressing topics including clinical innovation, care delivery, OCM learnings and implications for value-based care, automating behavior economics and analytics to improve palliative care, and scaling oncology disease expertise in urban and rural clinics.

The Swan Center for Plastic Surgery in Alpharetta Awarded 3 "Bests": Body Plastic Surgeon, Nose Plastic Surgery, and Non-Surgical Body Sculpting

Retrieved on: 
Wednesday, September 13, 2023

ATLANTA, Sept. 13, 2023 /PRNewswire/ -- The Swan Center for Plastic Surgery, located in Alpharetta, was nominated in numerous categories and won several awards in this year's Atlanta-area Best of 2023 awards: female board-certified plastic surgeon Dr. Cristen Catignani won Best Plastic Surgeon-Body in My Alpharetta, and the practice as a whole won Best Plastic Surgery for the Nose in Atlanta and Best Non Surgical Body Sculpting in My Alpharetta and My Johns Creek/Duluth.

Key Points: 
  • "We are honored to be recognized for excellence in both plastic surgery and non-surgical treatments by our community," said Dr. Joseph Bauer, founder of The Swan Center.
  • "Our team has been serving Atlanta patients for over 25 years; these awards are further testament to our range of skills and dependably excellent results."
  • Dr. Catignani regularly performs body cosmetic surgeries such as tummy tuck , liposuction , and mommy makeover in addition to breast reshaping procedures.
  • Board certified plastic surgeon Dr. Dean Fardo also practices at The Swan Center, specializing in procedures for the face—including nose plastic surgery, or rhinoplasty , for which the practice was awarded.

LEADING THE WAY IN INTEGRATIVE ONCOLOGY

Retrieved on: 
Wednesday, July 26, 2023

OVERLAND PARK, Kan., July 26, 2023 /PRNewswire/ -- The Riordan Clinic announces the addition of Dr. Stacy Dunn, ND, LAc, FABNO, FABORM, to its integrative oncology team. She will begin her practice at the Overland Park, Kansas, clinic location on July 31.

Key Points: 
  • OVERLAND PARK, Kan., July 26, 2023 /PRNewswire/ -- The Riordan Clinic announces the addition of Dr. Stacy Dunn, ND, LAc, FABNO, FABORM, to its integrative oncology team.
  • In addition to Dr. Dunn, the Riordan Clinic integrative oncology team also includes Chief Medical Officer Dr. Ron Hunninghake, MD, Dr. Kirsten West, ND, LAc, FABNO, and Laura Vasquez, MSN, APRN, NP-C.
    "Dr. Dunn brings a well-rounded blend of experience to our integrative oncology team.
  • To make an appointment with Dr. Dunn or the Riordan Clinic's other integrative oncology providers, call 1-800-447-7276.
  • Riordan Clinic is a world-renowned, academic medical center that has been leading the world in integrative oncology and complex chronic illness care since 1975.

ALiGN: A New Chapter in Medical Weight Loss and Fitness

Retrieved on: 
Wednesday, July 12, 2023

MARTHA'S VINEYARD, Mass., July 12, 2023 /PRNewswire/ -- ALiGN, a revolutionary, nationwide medical weight loss and fitness company founded by Dr. Dina BenDavid, DNP, MS, NP-C, is officially rolling out a nationwide program to help patients seeking to regain control of their health and wellness. ALiGN is on a mission to empower individuals to achieve their health and wellness goals through a combination of medical weight loss, fitness, smart dietary changes, and a supportive community.

Key Points: 
  • MARTHA'S VINEYARD, Mass., July 12, 2023 /PRNewswire/ -- ALiGN, a revolutionary, nationwide medical weight loss and fitness company founded by Dr. Dina BenDavid, DNP, MS, NP-C, is officially rolling out a nationwide program to help patients seeking to regain control of their health and wellness.
  • ALiGN is on a mission to empower individuals to achieve their health and wellness goals through a combination of medical weight loss, fitness, smart dietary changes, and a supportive community.
  • ALiGN's unique approach to wellness aims to bridge the gap between sustained and safe medical weight loss and lifestyle changes to enhance individuals lives and longevity.
  • By providing clients with a complete and integrated approach to wellness, ALiGN hopes to redefine the way people think about weight loss and fitness.

The American Med Spa Association Introduces the Women in Aesthetics Leadership Conference

Retrieved on: 
Saturday, June 17, 2023

CHICAGO, June 17, 2023 /PRNewswire-PRWeb/ -- The American Medical Spa Association (AmSpa) will present the inaugural Women in Aesthetics Leadership Conference (WALC) in Miami on November 1 – 3, 2023. This leadership retreat will take place at the plush 1 Hotel South Beach in beautiful Miami and will include a variety of sessions and activities designed to unlock attendees' leadership potential and nourish their souls. Faculty for the event features high-profile experts from the worlds of aesthetics and business, including Sara Blakely, founder and executive chairwoman of Spanx.

Key Points: 
  • Faculty for the event features high-profile experts from the worlds of aesthetics and business, including Sara Blakely, founder and executive chairwoman of Spanx.
  • "The Women in Aesthetics Leadership Conference has been developed from a sincere desire to feed the souls and minds of the women who power the medical aesthetics industry," says AmSpa COO, Cathy Christensen.
  • "We are so excited to premier the first Women's Aesthetic Leadership Conference," says AmSpa Sales Director Natalie Anderson.
  • For more information about the Women in Aesthetics Leadership Conference and to register to attend, visit http://www.americanmedspa.org/women-in-aesthetics .

Azafaros Announces Enrollment of First Patient in Phase 2 RAINBOW Study Evaluating AZ-3102 in GM2 and NP-C Patients

Retrieved on: 
Thursday, June 8, 2023

Azafaros B.V. today announced that the first patient has been enrolled into its Phase 2 RAINBOW study ( NCT05758922 ).

Key Points: 
  • Azafaros B.V. today announced that the first patient has been enrolled into its Phase 2 RAINBOW study ( NCT05758922 ).
  • Azafaros is developing the compound as a potentially disease-modifying treatment in severe metabolic disorders including GM1 and GM2 gangliosidoses and NP-C. Enrollment of the first patient in the study is an important milestone for Azafaros in its mission to bring new treatment options to these patients and their families.
  • The Phase 2 RAINBOW study is a randomized, double-blind, placebo-controlled, multicenter, 12-week trial assessing the safety, tolerability, pharmacokinetics, and pharmacodynamics of AZ-3102 in patients with GM2 gangliosidosis and NP-C.
  • Patients who complete the 12-week study period will be offered a double-blind extension if approved by the country’s health authorities.

IDgenetix® Shown to Significantly Improve Medication Response and Remission Rates in Patients with Major Depressive Disorder

Retrieved on: 
Wednesday, May 31, 2023

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced real-world study data demonstrating that use of IDgenetix® to guide medication management can significantly improve medication response and remission rates in patients diagnosed with moderate to severe depression, compared to current standard-of-care treatment.

Key Points: 
  • Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced real-world study data demonstrating that use of IDgenetix® to guide medication management can significantly improve medication response and remission rates in patients diagnosed with moderate to severe depression, compared to current standard-of-care treatment.
  • The data was shared via a poster presentation at the May 2023 American Psychiatric Association (APA) Annual Meeting held in San Francisco.
  • “As supported by the data in this study, using IDgenetix to guide personalized medication selection can help improve the care of patients suffering from moderate to severe depression by offering hope of improved medication response and remission.”
    In the study, patients whose medication management was guided by IDgenetix achieved a 35% increase in medication response and a 64% increase in remission rate at eight weeks compared to patients whose medication was not guided by the test.
  • In an RCT, patients diagnosed with severe depression whose medication management was guided by the IDgenetix test showed a greater than two and a half times improvement in remission rates at eight and 12 weeks compared to those who were not guided by IDgenetix.1

Immersive Virtual Reality Training From Wolters Kluwer & Laerdal Medical Transports Nursing Students to a Busy Hospital Floor

Retrieved on: 
Thursday, January 19, 2023

Wolters Kluwer, Health and Laerdal Medical today announced the development of vrClinicals for Nursing , an immersive, virtual reality (VR) nursing education experience designed to strengthen practice readiness.

Key Points: 
  • Wolters Kluwer, Health and Laerdal Medical today announced the development of vrClinicals for Nursing , an immersive, virtual reality (VR) nursing education experience designed to strengthen practice readiness.
  • View the full release here: https://www.businesswire.com/news/home/20230119005186/en/
    vrClinicals for Nursing prepares students for medical practice by building clinical judgment and multi-patient prioritization skills.
  • “Using immersive virtual reality, vrClinicals for Nursing allows students to benefit from clinical training in a controlled environment where they can safely make and learn from their mistakes,” said Julie Stegman , Vice President, Nursing Segment, Health Learning, Research & Practice at Wolters Kluwer, Health.
  • vrClinicals for Nursing, which was co-developed with Laerdal Medical, builds on the successful collaboration between Laerdal Medical and Wolters Kluwer.

Azafaros Receives FDA's IND Clearance and Fast Track Designation for Lead Asset AZ-3102

Retrieved on: 
Thursday, January 5, 2023

The study is being conducted in the U.S. as well as in other countries.

Key Points: 
  • The study is being conducted in the U.S. as well as in other countries.
  • The pharmacodynamics and the impact of AZ-3102 on potential disease biomarkers will also be measured during the trial.
  • AZ-3102 has unique characteristics that confer the potential to be an effective therapeutic innovation for these patients,” said Professor Patterson.
  • Stefano Portolano, MD, Chief Executive Officer of Azafaros, added: “The IND clearance and Fast Track Designation highlight AZ-3102’s potential and demonstrate the ability of the Azafaros team to achieve our ambitious goals.

FLORIDA SOUTHERN COLLEGE DOCTOR OF NURSING PRACTICE STUDENTS PRESENT CAPSTONE PROJECTS

Retrieved on: 
Thursday, August 11, 2022

LAKELAND, Fla., Aug. 11, 2022 /PRNewswire/ -- Members of the second graduating class of the Florida Southern College Doctor of Nursing Practice program presented their capstone project posters in the Joe K. and Alberta Blanton Nursing Building, on August 4th, 2022.

Key Points: 
  • LAKELAND, Fla., Aug. 11, 2022 /PRNewswire/ -- Members of the second graduating class of the Florida Southern College Doctor of Nursing Practice program presented their capstone project posters in the Joe K. and Alberta Blanton Nursing Building, on August 4th, 2022.
  • The seven-member cohort completed community- and practice- based health care improvement projects.
  • "I am delighted with the results of the DNP projects completed by students in the summer 2022 graduating DNP cohort," Dr. Michael said.
  • Florida Southern has a 14:1 student-to-faculty ratio, is an award-winning national leader in engaged learning, and boasts 30 NCAA Division II National Championships.